Addition of taxanes to combination chemotherapy in distal intestinal gastric cancer is more beneficial than proximal ones: A multicenter retrospective study of Turkish Oncology Group

Sadeleştirilmiş öğe sayfası
dc.contributor.authorSedef, Ali Murat
dc.contributor.authorKose, Fatih
dc.contributor.authorSumbul, Ahmet Taner
dc.contributor.authorBesen, Ali Ayberk
dc.contributor.authorHacioglu, Bekir
dc.contributor.authorGunaldi, Meral
dc.contributor.authorNayir, Erdinc
dc.contributor.authorTanriverdi, Ozgur
dc.contributor.authorArpaci, Erkan
dc.contributor.authorAbali, Huseyin
dc.contributor.authorOzyilkan, Ozgur
dc.date.accessioned2025-10-16T15:24:07Z
dc.date.issued2019
dc.identifier.otherWOS:000464461100035
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/8063
dc.publisherIMPRIMATUR PUBLICATIONS
dc.sourceJOURNAL OF BUON
dc.subjectgastric cancer
dc.subjecttumor location
dc.subjectpathology
dc.subjectoutcome
dc.titleAddition of taxanes to combination chemotherapy in distal intestinal gastric cancer is more beneficial than proximal ones: A multicenter retrospective study of Turkish Oncology Group
dc.typeArticle

Dosyalar

Koleksiyonlar

WOS